Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome

por Davies, Helen R., Hodgson, Kirsty, Schwalbe, Edward, Coxhead, Jonathan, Sinclair, Naomi, Zou, Xueqing, Cockell, Simon, Husain, Akhtar, Nik-Zainal, Serena, Rajan, Neil
Publicado en Nat Commun (2019)

Overexpression of MYB drives proliferation of CYLD‐defective cylindroma cells

por Rajan, Neil, Andersson, Mattias K, Sinclair, Naomi, Fehr, André, Hodgson, Kirsty, Lord, Christopher J, Kazakov, Dmitry V, Vanecek, Tomas, Ashworth, Alan, Stenman, Göran
Publicado en J Pathol (2016)

Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial

por Danilenko, Marina, Stamp, Elaine, Stocken, Deborah D., Husain, Akhtar, Zangarini, Monique, Cranston, Amy, Stones, Robert, Sinclair, Naomi, Hodgson, Kirsty, Bowett, Susan A., Roblin, David, Traversa, Silvio, Plummer, Ruth, Veal, Gareth, Langtry, James A. A., Ashworth, Alan, Burn, John, Rajan, Neil
Publicado en JAMA Dermatol (2018)